title: The role of physical medicine and rehabilitation in haemophiliac patients.
abstract: Physical medicine and rehabilitation aim to evaluate, diagnose and treat disability in haemophiliac patients, while preventing injury or deterioration. They also aim to maintain the greatest degree of functional capacity and independence in patients with haemophilia, or to return them to that state. Rehabilitation, together with clotting factor replacement therapy, has revolutionized the management of these patients in developed countries and reduced their morbidity/mortality rates. A knowledge of the musculoskeletal signs and symptoms of haemophilia is essential for providing a treatment which is suitable and customized. Physical medicine and rehabilitation techniques, which are based on physical means, are intended to reduce the impact which these injuries and their consequences or sequelae can have on the quality of life of patients with haemophilia. Under ideal haemostatic control conditions (primary prophylaxis), people with haemophilia could achieve good physical condition which will allow them to enjoy both physical activity and a daily life without limitations. Currently, children undergoing primary prophylaxis are quite close to this ideal situation. For these physical activities to be carried out, the safest possible situations must be sought.
authors.affiliation: Department of Physical Medicine and Rehabilitation, La Paz University Hospital, Madrid, Spain.
authors.forename: Hortensia
authors.initials: H
authors.lastname: De la Corte-Rodriguez
authors.forename: E Carlos
authors.initials: EC
authors.lastname: Rodriguez-Merchan
mesh_terms: D001845:Bone Cysts / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy; D002357:Cartilage Diseases / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy; D002358:Cartilage, Articular / Q000473:pathology; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004599:Electric Stimulation Therapy; D005081:Exercise Therapy; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005944:Glucosamine / Q000627:therapeutic use; D006395:Hemarthrosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy / Q000534:rehabilitation*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D006984:Hypertrophy; D009043:Motor Activity; D009140:Musculoskeletal Diseases / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation* / Q000628:therapy; D010810:Physical and Rehabilitation Medicine; D000074402:Synovectomy; D013583:Synovial Membrane / Q000473:pathology; D013585:Synovitis / Q000209:etiology / Q000517:prevention & control / Q000532:radiotherapy / Q000534:rehabilitation / Q000601:surgery; D004561:Transcutaneous Electric Nerve Stimulation
chemical_list: D005169:Factor VIII; D005164:Factor IX; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates; D005944:Glucosamine